Search Results 521-530 of 21350 for anti-TNF drugs

  1. Artemether And Lumefantrine (Oral Route) Description and Brand Names - Mayo Clinic

    Artemether and lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by ...

  2. Infectious diseases - Diagnosis & treatment - Mayo Clinic

    More-severe internal organ fungal infections, especially in people with weakened immune systems, may require intravenous antifungal medications. Anti-parasitics.

  3. Skin cancer - Diagnosis and treatment - Mayo Clinic

    In chemotherapy, drugs are used to kill cancer cells. For cancers limited to the top layer of skin, creams or lotions containing anti-cancer agents may be ...

  4. Corticosteroid (Dental Route) Description and Brand Names - Mayo Clinic

    Descriptions. Dental corticosteroids are used to relieve the discomfort and redness of some mouth and gum problems. These medicines are like cortisone. They ...

  5. Milk thistle - Mayo Clinic

    Milk thistle may affect how your liver processes this osteoporosis medication, causing higher levels of the drug in your bloodstream. Talk to your doctor before ...

  6. Sulfonamide (Oral Route) Before Using - Mayo Clinic

    Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

  7. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

  8. Zinc - Mayo Clinic

    People use oral zinc to help treat colds, but it can decrease the effectiveness of certain drugs and cause side effects. ... These blood pressure drugs increase ...

  9. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

  10. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...